Espoo, October 6th, 2023. Euformatics has entered into a partnership with Genetrics to serve as their channel partner for the distribution of their NGS data analysis software in the Middle East. This strategic collaboration aims to improve the accessibility of Euformatics’ solutions in the healthcare industry, specifically focusing on optimising patient diagnosis. Through this joint effort, Euformatics and Genetrics endeavour to elevate the quality of healthcare services in the region.
Euformatics offers a range of bioinformatics tools for analysing NGS data. Their partnership includes the complete Genomics Hub, which encompasses the comprehensive quality control module and the secondary and tertiary analysis modules. The quality control tool calculates more than 60 quality metrics from the standard bioinformatics files produced by NGS workflows. The secondary analysis performs read alignment and calling of different variant types from the sample (small variants, structural variants). The resulting data can then be analysed by the tertiary analysis tool that performs variant annotation, classification, interpretation and reporting. These tools can help researchers, clinicians, pathologists, and geneticists to analyse NGS samples – with confidence – from small gene panels to whole genomes.
G. Varadharaj, Technical Director of Genetrics, says: “I am delighted to talk about our partnership with Euformatics. Our collaboration has been tremendously advantageous for both of our organisations. By pooling our knowledge and expertise, we will drive innovation and growth in our industry. It has been a pleasure to work with the Euformatics team so far, and we look forward to continuing our partnership for many years to come.”
Euformatics’ CEO, Tommi Kaasalainen, continues, “I am thrilled to announce our partnership with Genetrics as our new channel partner for distributing our NGS data analysis software in the Middle East. It’s important to provide better accessibility to high-quality genetic testing in the healthcare industry, resulting in improved patient diagnosis and better quality of healthcare services in the region. I am grateful for the opportunity to work with the Genetrics team and look forward to a long and successful partnership. ”
Euformatics’ partnership with Genetrics will deepen their understanding of the local market and navigate them through unique and challenging market trends. Euformatics aims to strengthen its presence in the Middle East market.
At Genetrics, our team of professionals has been collaborating with pioneers in the medical and scientific industries for decades, helping them market their products in the Middle East and Asian markets. Our continuous growth is a direct response to our customers’ needs, and today, we offer complete turnkey solutions for all their healthcare scientific requirements. Our range of technologies and systems includes medical and laboratory equipment, biological sample collection, processing and storage management, analytical systems, reagents and research chemicals, high-performance computing, bioinformatics, lab information management systems, network and database management, seamless integration of NGS platforms, Human Identity management for DNA database projects, and tools for validation and compliance management. We are dedicated to serving our clients in the Middle East and providing them with the best possible solutions for their needs.
To learn more, visit https://www.genetricsinc.com/
Euformatics is a Finnish software company specialising in high-standard bioinformatics tools for interpreting genomic data. Since 2010, Euformatics has been helping medical doctors and molecular genetics laboratories provide better precision medicine for cancer and common or rare disease diagnostics. Our core solution is the Genomics Hub, which includes a variant interpretation tool for clinical analysis and reporting of patient NGS data and a quality control tool for NGS data quality management.
To learn more, visit www.euformatics.com